Heteroaromatic glucokinase activators

Details for Australian Patent Application No. 2005311269 (hide)

Owner TransTech Pharma, Inc.

Inventors Kristiansen, Marit; Jeppesen, Lone

Agent Shelston IP

Pub. Number AU-B-2005311269

PCT Pub. Number WO2006/058923

Priority PA 2004 01888 03.12.04 DK

Filing date 5 December 2005

Wipo publication date 8 June 2006

Acceptance publication date 10 November 2011

International Classifications

C07D 277/46 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

C07D 277/54 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/058923 Priority application(s): WO2006/058923

14 February 2008 Assignment before Grant

  Novo Nordisk A/S The application has been assigned to Transtech Pharma, Inc. 2006

10 November 2011 Application Accepted

  Published as AU-B-2005311269

8 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311274-Safety device for child seats for vehicles

2005311266-Use of omega-3 fatty acid(s) for treating hypercholesterolemia caused by antiretroviral treatment of HIV-infected patients